• Find people
• Intranet

Infectious Pathology and Antimicrobials Juan Pablo Horcajada

Publications 2024 (55)

• Planella-Fontanillas N^*, Rial A, Villar-García J, Parra-Navarro L, Santiago P, Pujol RM, Rodríguez-Morera J. Hepatic inflammatory pseudotumours mimicking metastatic disease in a non-HIV patient with secondary syphilis. J Eur Acad Dermatol Venereol 2024: (en Premsa).
• Aggarwal NR^*, Nordwall J, Braun DL, Chung L, Coslet J, Der T, Eriobu N, Ginde AA, Hayanga AJ, Highbarger H, Holodniy M, Horcajada JP, Jain MK, Kim K, Laverdure S, Lundgren J, Natarajan V, Nguyen HH, Pett SL, Phillips A, Poulakou G, Price DA, Robinson P, Rogers AJ, Sandkovsky U, Shaw-Saliba K, Sturek JM, Trautner BW, Waters M, Reilly C, ACTIV-3/TICO Study Group. Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19. Clin Infect Dis 2024: (en Premsa).
• de Pando T, Grau S, Almendral A, Echeverría-Esnal D, Hernández S, Limón E, Pontes C. Long-term impact of COVID-19 pandemic on antibiotic use in primary care: lessons to optimize antimicrobial use. Expert Rev Anti Infect Ther 2024: 1-15 (en Premsa).
• Horcajada JP^*, Edwards F, Fonio S, Montero MM, Harris P, Paterson DL, Laupland KB. Pseudomonas stutzeri bloodstream infection is a prevailing community-onset disease with important mortality rates: results from a retrospective observational study in Australia. Infect Dis 2024: 1-10 (en Premsa).
• Pardo-Pol A^*, FONTANELLAS A, Pérez-Prieto D, Sorli L, Hinarejos P, Monllau JC. The Use of Erythromycin and Colistin Cement in Total Knee Arthroplasty Does Not Reduce the Incidence of Infection: A Randomized Study in 2,893 Knees With a 9-year Average Follow-Up. J Arthroplasty 2024: (en Premsa).
• Butragueño-Laiseca L, Troconiz IF, Grau S, Campillo N, Padilla B, Fernández SN, Slöcker M, Herrera L, Santiago MJ^*. How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children. Antimicrob Agents Chemother 2024: (en Premsa).
• Lopez Montesinos I, Carot-Coll A, Montero MM, Sorli L, Siverio-Pares A, Esteban-Cucó S, Duran X, Gómez-Zorrilla S^*, Horcajada JP. A case-control study of the clinical and economic impact of infections caused by Carbapenemase-producing Enterobacterales (CPE). Infection 2024: (en Premsa).
• Williams P^*, Cotta MO, Tabah A, Sandaradura I, Kanji S, Scheetz MH, Imani S, Elhadi M, Luque S, Schellack N, Sanches C, Timsit JF, Xie J, Farkas A, Wilks K, Roberts JA, European Society of Intensive Care Medicine (ESICM) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients [ESGCIP]. Antimicrobial therapeutic drug monitoring in critically ill adult patients - An international perspective on access, utilisation, and barriers. Int J Antimicrob Ag 2024; 64: (en Premsa).
• Barbero-Allende JM^*, Fernández-Antón E, Gómez J, Sorli L, Rodriguez-Pardo D, Murillo-Rubio O, Fernández-Sampedro M, Escudero-Sánchez R, Garcia-Gutiérrez M, Portillo ME, Sancho I, Rico-Nieto A, Guio-Carrion L, Soriano-Viladomiu A, Morata-Ruiz L, De Abajo-Iglesias F. Impact of antibiotic prophylaxis in second-stage surgery in joint prosthesis infection treated with two-stage exchange. A multicenter case-control study. Eur J Clin Microbiol Infect Dis 2024: (en Premsa).
• Giménez-Pérez M^*, Hernández S, Padullés A, Boix Palop L, Grau S, Badia JM, Ferrer R, Calbo E, Limón E, Pujol M, Horcajada JP, Members of the E. coli Study Group, on behalf of VINCat Program. Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia. Int J Antimicrob Ag 2024; 64: (en Premsa).
• Colominas-González E, de Antonio-Cuscó M, Masip M, Martín-Conde MT, Cardona G, Fresán-Restituto D, Comas D, Roch MA, López B, Torres-Bondia FI, Retamero A, Knobel H, Luque S^*. Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy. Eur J Hosp Pharm Sci Pract 2024: (en Premsa).
• Luque S^*, Sorli L^*, Li J, Fernández X, Berenguer N, Colominas-González E, Benitez-Cano A, Montero MM, Subirana I, Prim N, Garcia-Paricio R, Horcajada JP, Grau S. New Predictive Equation for the Estimation of Plasma Concentrations of Formed Colistin in Patients Treated with Colistimethate Sodium for Multidrug-Resistant Gram-Negative Bacterial Infections. Ther Drug Monit 2024: (en Premsa).
• Llibre JM^*, Revollo B, Aceiton J, Díaz Y, Domingo P, Burgos J, Sorni P, Saumoy M, Knobel H, Navarro M, Leon E, Orti A, Arbonés L, Mera A, Deig E, Sirera G, Miró JM, Casabona J, Martín-Iguacel R, PISCIS Cohort Study Group. Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohort. Lancet HIV 2024: (en Premsa).
• Garcia JR^*, Olivero R, Arrieta I, Romero JA, Riera E, Cañas-Ruano E, Garrido N, Du J, Güerri R. Association between cardiovascular inflammation and alterations in immune system induced by HIV infection detected on [(18)F]FDG PET/MRI. Rev Esp Med Nucl Imagen Mol 2024: (en Premsa).
• Palacio JA^*, Díaz Y, Moreno-Fornes S, Bruguera A, Nomah DK, Llibre JM, Knobel H, Chivite I, Miró JM, Suanzes P, Fanjul F, Navarro G, Macorigh L, Homar-Borràs F, Vilaró-López I, Orti-Llaveria AJ, Casabona J, Imaz A, Reyes JM, PISCIS Study Group. Developing and validating a clinical risk score to predict losses in the PISCIS cohort of people with HIV. Int J Std Aids 2024: (en Premsa).
• Dinh A^*, Mcnally M, D'anglejan E, Mamona Kilu, Lourtet J, Ho R, Scarborough M, Dudareva M, Jesuthasan G, Ronde-Oustau C, Klein S, Escolà-Vergé L, Rodriguez-Pardo MD, Delobel P, Lora-Tamayo J, Mancheño-Losa M, Sorli L, Barbero-Allende JM, Arvieux C, Vaznaisiène D, Bauer T, Roux AL, Noussair L, Corvec S, Fernández-Sampedro M, Rossi N, Lemaignen A, Costa-Salles MJ, Cunha-Ribeiro T, Mazet J, Sasso M, Lavigne JP, Sotto A, Canouï E, Senneville É, Thill P, Lortholary O, Lanternier F, Morata-Ruiz L, Soriano A, Giordano G, Fourcade C, Franck BJH, Hofstätter JG, Duran C, Bonnet E, European Society of Clinical Microbiology and Infectious Diseases Study Group on Implant Associated Infections (ESGIAI). Prosthetic Joint Infections due to Candida Species: A Multicenter International Study. Clin Infect Dis 2024: (en Premsa).
• Montero MM^*, Domene-Ochoa S, Prim N, Ferola EB, López Causapé C, Echeverría-Esnal D, Morisaki MFA, Vega-Toribio V, Sorli L, Luque S, Padilla E, Oliver A, Horcajada JP^*. Synergistic efficacy of ceftazidime/avibactam and aztreonam against carbapenemase-producing Pseudomonas aeruginosa: insights from the hollow-fiber infection model. Infect Dis 2024: 1-8 (en Premsa).
• Mancheño-Losa M, Murillo O^*, Benavent E, Sorli ML, Riera M, Cobo J, Benito N, Morata L, Ribera A, Sobrino B, Fernández-Sampedro M, Múñez E, Bahamonde A, Barbero JM, del Toro MD, Villa J, Rigo-Bonnin R, Luque S, García-Luque I, Oliver A, Esteban J, Lora-Tamayo J. Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study. Infection 2024: (en Premsa).
• Güerri R^*, Benet J, Vargas C. Medical-legal aspects in infectious diseases. Med Clin (Barc) 2024: (en Premsa).
• Pau-Parra A, Núñez-Núñez M^*, Sadyrbaeva-Dolgova S, Doménech-Moral L, Campelo-Sánchez E, Periañez-Parraga LDM, Saeed-Khan K, Luque S. National Survey and consensus document on dosing strategies for beta-lactam antibiotics against multidrug-resistant gram-negative bacilli (MDR-GNB) in critically ill patients undergoing extracorporeal life support techniques: The DOSEBL study protocol. Farm Hosp 2024: (en Premsa).
• Luque S, Hope W, Kotsaki A, Das S, Giamarellos-Bourboulis EJ, Kontopoulouk T, Akinosoglou K, O'hare M, Attwood MLG, Bowker KE, Noel AR, Lovering AM, Bayliss MAJ, Evans RN, MacGowan AP^*. Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA. J Antimicrob Chemother 2024: (en Premsa).
• Sendra E, Fernandez-Muñoz A, Zamorano L, Oliver A, Horcajada JP^*, Juan C, Gómez-Zorrilla S^*. Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective. Infection 2024; 52: 1235-1268.
• Luque S, Mendoza-Palomar N^*, Aguilera-Alonso D, Garrido B, Miarons M, Piqueras AI, Tévar E, Velasco-Arnaiz E, Fernández-Polo A. Spanish Society of Hospital Pharmacy and the Spanish Society of Pediatric Infectious Diseases (SEFH-SEIP) National Consensus Guidelines for therapeutic drug monitoring of antibiotic and antifungal drugs in pediatric and newborn patients. Farm Hosp 2024; 48(5): 234-245.
• Luque S, Mendoza-Palomar N^*, Aguilera-Alonso D, Garrido B, Miarons M, Piqueras AI, Tévar E, Velasco-Arnaiz E, Fernández-Polo A. [Translated article] Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP). Farm Hosp 2024; 48(5): T234-T245.
• Cortes-Lara S, Medina-Reatiga P, Barrio-Tofiño E, Gomis-Font MA, Cabot G, Gómez-Romano F, Ayestarán I, Colomar A, Palou A, Oteo-Iglesias J, Del Campo R, Cantón R, Horcajada JP, López Causapé C^*, Oliver A^*. Monitoring of Pseudomonas aeruginosa mutational resistome dynamics using an enrichment panel for direct sequencing of clinical samples. EBioMedicine 2024; 108: 105367.
• Pedreira-Robles G, Bach-Pascual A, Collado S, Padilla E, Burballa C, Arias-Cabrales C, Redondo D, Sánchez F, Horcajada JP, Pascual J, Crespo M, Villar-García J, Pérez Sáez MJ^*. Screening for tropical and imported infections in migrant kidney transplant candidates from the kidney transplant access consultation. Nefrología 2024: (en Premsa).
• Gómez-Zorrilla S^*, Becerra F, Sendra E, Zamorano L, Grau I, Pintado V, Padilla B, Benito N, Boix L, Fariñas MDC, Penaranda M, Gamallo MR, Martinez JA, Morte-Romea E, Del Pozo JL, Lopez Montesinos I, Duran X, Ponz R, Cortarelo M, Cantón R, Oliver A, Ruiz-Garbajosa P, Horcajada JP^*, ITUBRAS-2 Group. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain. J Hosp Infect 2024; 151: 173-185.
• Sastre-Femenia MÀ, Fernandez-Muñoz A, Gomis-Font MA, Taltavull B, López Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A^*, GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group (...,Horcajada JP,...). Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis. Lancet Reg Health Eur . 2024; 34: 100736 (Acceptat).
• Luque S^*, Mendoza-Palomar N^*, Aguilera-Alonso D, Garrido B, Miarons M, Piqueras AI^*, Tévar E, Velasco-Arnaiz E^*, Fernández-Polo A^*. Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP). An Pediatr (Barc) 2024; 101(3): 190-207.
• Pairo-castineira E, Rawlik K, Bretherick AD, Qi T, Wu Y, Nassiri I, Mcconkey GA, Zechner M, Klaric L, Griffiths F, Oosthuyzen W, Kousathanas A, Richmond A, Millar J, Russell CD, Malinauskas T, Thwaites R, Morrice K, Keating S, Maslove D, Nichol A, Semple MG, Knight J, Shankar-Hari M, Summers C, Hinds C, Horby P, Ling L, Mcauley D, Montgomery H, Openshaw PJM, Begg C, Walsh T, Tenesa A, Flores C, Riancho JA, Rojas-martinez A, Lapunzina P, Yang J, Ponting CP, Wilson JF, Vitart V, Abedalthagafi M, Luchessi AD, Parra EJ, Cruz R, Carracedo A, Fawkes A, Murphy L, Rowan K, Pereira AC, Law A, Fairfax B, Hendry SC, Baillie JK^*, 23andMe COVID-19 Team (...,Horcajada JP,...). GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature 2024; 617(7962): 764-768.
• Ortonobes S^*, Herranz S, Lleal M, Sevilla-Sánchez D, Jordana R, Mascaró O, Ferrandez O, de Jaime E, Estrada R, Nazco GJ, Baré M^*, MoPIM Study Group. Multidisciplinary medication review during older patient hospitalization according to STOPP/START criteria reduces potentially inappropriate prescriptions: MoPIM cohort study. BMC Geriatr 2024; 24(1): 584.
• Sacanella I, Esteve-Pitarch E, Guevara-Chaux J, Berrueta J, García-Martínez A, Gomez J, Casarino C, Alés F, Canadell L, Martin-Loeches I, Grau S, Candel FJ, Bodí M, Rodriguez A^*. A Real-World Data Observational Analysis of the Impact of Liposomal Amphotericin B on Renal Function Using Machine Learning in Critically Ill Patients. Antibiotics (Basel) . 2024; 13(8): 760.
• Ferrandez O^*, Grau S, Colominas-González E, Navarrete ME, Carballo N, de Antonio-Cuscó M, Fernández-Sala X, Río-No L, Fando-Romera O, Berzosa-Malagon M, Pineda-Rodriguez S, Torres-Rius N, Duran X, Rodríguez-Caba C, Casas-Sánchez J, Caro-Herranz F, Pontes-García C. Dispensation of outpatient hospital medicines by hospital only versus hospital-community pharmacies collaboration: a cross-sectional study and survey of patient's satisfaction. Front Public Health 2024; 12: 1335265 (Acceptat).
• Shields RK, Horcajada JP, Kamat S^*, Irani PM, Tawadrous M, Welte T. Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis. Infect Dis Ther . 2024; 13(7): 1639-1664.
• Lightowler MS^*, Sander JV, García de Casasola-Sanchez G, Mateos-González M, Güerri-Fernández R, Lorenzo-Navarro MD, Nackers F, Stratta E, Lanusse C, Huerga H. Evaluation of a Lung Ultrasound Score in Hospitalized Adult Patients with COVID-19 in Barcelona, Spain. J Clin Med 2024; 13(11): 3282.
• Coelho A^*, Alier A, Martínez-Díaz S, Puig L, Gómez J, Garcia-Bernedo CA, Pérez-Prieto D. High Rate of Undetected Infections in Failed Osteosynthesis of Pertrochanteric Fractures. J Orthop Trauma 2024; 38(6): 327-332.
• Casella V^*, Cebollada-Rica P, Argilaguet J, Vidal E, González-Cao M, Güerri-Fernández R, Bocharov G, Meyerhans A^*. Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis. Viruses 2024; 16(5): 799.
• Salmanton-García J, Bruns C, Rutz J, Albertsmeier M, Ankert J, Bernard L, Bataille C, Couvé-Deacon E, Fernandez-Ferrer M, Fortún J, Galar A, Grill E, Guimard T, Classen AY, Vehreschild JJ, Stemler J, Naendrup JH, Hampl J, Tallon B, Sprute R, Horcajada JP, Mollar-Maseres J, Muñoz P, Pletz MW, Serracino-Inglott F, Soriano A, Vilz TO, Seifert H, Cornely OA, Mellinghoff SC^*, Liss BJ, Wingen-Heimann SM, SALT study group. Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK. J Hosp Infect 2024; 147: 123-132.
• Ramos-Delgado I, Benítez-Cano A^*, Luque S, Sorli L, Adalia R. [Penetration in cerebrospinal fluid and use of ceftaroline in ventriculitis associated with external ventricular drainage]. Rev Esp Quimioter 2024; 37(2): 189-190.
• Caguana OA, Khilzi K, Piccari L, Rodríguez-Sevilla JJ, Badenes D, González-Garcia J, Chalela R, Arita M, Rodó A, Herranz A, Admetllo M, Villar-García J, Molina L, Zuccarino F, Gea J, Balcells E, Rodríguez-Chiaradia DA^*. Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2. Respiration 2024; 103(2): 79-87.
• Nomah DK^*, Jamarkattel S, Bruguera A^*, Moreno-Fornes S, Díaz Y, Alonso L, Aceitón J, Llibre JM, Domingo P, Saumoy M, Homar F, Fanjul F, Navarro J, de la Mora L, Knobel H, Orti A, Martín-Iguacel R, Miró JM, Casabona J, Reyes JM. Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998-2020. Open Forum Infect Dis 2024; 11(4): ofae132 (Acceptat).
• Benito N^*, Martínez-Pastor JC, Lora-Tamayo J, Ariza J, Baeza J, Belzunegui-Otano J, Cobo J, del Toro MD, Fontecha CG, Font-Vizcarra L, Horcajada JP, Morata-Ruiz L, Murillo O, Nolla JM, Núñez-Cuadros E, Pigrau C, Portillo ME, Rodriguez-Pardo D, Sobrino-Diaz B, Saavedra-Lozano J. Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT. Enferm Infecc Microbiol Clin 2024; 42(4): 208-214.
• Thompson GR^*, Soriano A, Honore PM, Bassetti M, Cornely OA, Kollef M, Kullberg BJ, Pullman J, Hites M, Fortún J, Horcajada JP, Kotanidou A, Das AF, Sandison T, Aram JA, Vazquez JA, Pappas PG. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials. Lancet Infectious Diseases 2024; 24(3): 319-328.
• Royo-Cebrecos C, Laporte-Amargós J^*, Peña M, Ruiz-Camps I, García-Vidal C, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Paz-Morales HM, Brunel AS, Garcia E, Isler B, Kern WV, Palacios-Baena ZR, de la Calle GM, Montero MM, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatii P, Araos R, Peghin M, del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, Gudiol C^*, IRONIC Study Group. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy. Microorganisms . 2024; 12(4): 705.
• Ambrosioni J^*, Díaz NA^*, Marzolini C, Dragovic G, Imaz A, Calcagno A, Luque S, Curran A, Troya J, Tuset M, Khoo S, Burger D, Cortés CP, Naous N, Molto J. Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study. Infect Dis Ther . 2024; 13(3): 609-617.
• Camps-Vilaró A, Pinsach-Abuin ML, Dégano IR, Ramos R, Martí-Lluch R, Elosua R, Subirana I, Solà C, Puigmulé M, Perez A, Vilaró I, Cruz R, Diz-de Almeida S, Nogués X, Masclans JR, Güerri R, Marin J, Tizon H, Vaquerizo B, Brugada R, Marrugat J^*. Genetic characteristics involved in COVID-19 severity. The CARGENCORS case-control study and meta-analysis. J Med Virol 2024; 96(2): e29404.
• Horcajada JP^*, Aldonza R, Real M, Espinosa S, Sendra E, Gómez J, Lopez Montesinos I, Gómez-Zorrilla S, Briansó S, Duran-Taberna M, Fernandez A, Tarragó C, Auguet-Quintillá T, COVID-HJ23 group. Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID). Pneumonia 2024; 16(1): 3.
• Sisteré-Oró M, Du J, Wortmann DDJ, Filippi MD, Cañas-Ruano E, Arrieta I, Marcos A, Castells X, Grau S, García-Giralt N, Perez-Zsolt D, Boreika R, Izquierdo-Useros N, Güerri R^*, Meyerhans A^*. Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination. J Med Virol 2024; 96(1): e29317.
• Torrens C^*, Bellosillo B, Gibert J, Suarez-Lopez A, Santana F, Alier A. Are Cutibacterium acnes delivered from skin to deep tissues in primary reverse shoulder arthroplasty? A prospective study. Arch Orthop Traum Su 2024; 144(2): 635-640.
• Rodriguez-Alarcon A, Sanz de Mena M, Alanti SS, Echeverría-Esnal D, Sorli L, Sendra E, Benítez-Cano A, Membrilla-Fernandez E, Cots F, Güerri R, Adalia R, Horcajada JP, Escolano F, Grau S, Gómez-Zorrilla S^*. A retrospective case-control study to evaluate the use of beta-lactam desensitization in the management of penicillin-allergic patients: a potential strategy for Antimicrobial Stewardship Programs. Front Pharmacol 2024; 14: 1260632 (Acceptat).
• Aguilera L, Gallart L^*, Ramos-Delgado I, Duran X, Escolano F. Effects of midline laparotomy on cough strength: a prospective study measuring cough pressure. Minerva Anestesiol 2024; 89(12): 1092-1098.
• Coelho A^*, Pares-Alfonso I, Companys R, Sánchez-Soler JF, Torres-Claramunt R, Alier A, Monllau JC. Risk factors for infection of tibial plateau fractures. Revista Española de Cirugía Ortopédica y Traumatología 2024; 68(1): 44-49.
• Grau S, Vela JM, Gurt A, Barceló-Vidal J, Ojeda FA, Lopez I, Gómez-García L, Loza MI, Martín-García E, Maldonado R^*, Monfort J, SIGMA Group. Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients. J. Infect. 2024; 88(2): 187-190.
• Bodilsen J^*, D'Alessandris QG, Humphreys H, Iro MA, Klein M, Last K, Lopez Montesinos I, Pagliano P, Sipahi OR, San-Juan R, Tattevin P, Thurnher M, de J Treviño R, Brouwer MC, ESCMID Study Group for Infections of the Brain (ESGIB). European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults. Clin Microbiol Infec 2024; 30(1): 66-89.
• Bodilsen J^*, D'Alessandris QG, Humphreys H, Iro MA, Klein M, Last K, Lopez Montesinos I, Pagliano P, Sipahi OR, San-Juan R, Tattevin P, Thurnher M, de J Treviño R, Brouwer MC, ESCMID Study Group for Infections of the Brain (ESGIB). "European Society of Clinical Microbiology and infectious Diseases Guidelines on diagnosis and treatment of brain abscess in children and adults". Clin Microbiol Infec 2024; 30(1): 149-150.